Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer Centers

Progress in the management of rare diseases, including rare cancers, is dependent upon clinical trials; however, as many as 32% of rare-disease trials go uncompleted or unpublished due to insufficient accrual. Monitoring practices may differ between institutions. We sought to survey the regulatory s...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Zachary T., Goldberg, Zachary, Philips, Ramez, Johnson, Jennifer M., Kasner, Margaret T., Kelly, William K., Osipowicz, Sarah, Dampman, Rachael, Curry, Joseph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498538/
https://www.ncbi.nlm.nih.gov/pubmed/36136866
http://dx.doi.org/10.3390/clinpract12050072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498538/
https://www.ncbi.nlm.nih.gov/pubmed/36136866
http://dx.doi.org/10.3390/clinpract12050072

Ejemplares similares